D.E. Shaw & Co’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

D.E. Shaw & Co’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-120,000	Closed	-$15.2M	–	3743
2016 Q3	$15.2M	Hold	120,000	–	–	0.03%	696
2016 Q2	$17.4M	Hold	120,000	–	–	0.03%	597
2016 Q1	$16.9M	Buy	120,000 +10,000	+9%	+$1.34M	0.03%	612
2015 Q4	$15.9M	Buy	110,000 +25,000	+29%	+$3.76M	0.02%	743
2015 Q3	$12.6M	Hold	85,000	–	–	0.02%	835
2015 Q2	$11.6M	Hold	85,000	–	–	0.02%	933
2015 Q1	$10.5M	Buy	85,000 +60,000	+240%	+$7.16M	0.02%	933
2014 Q4	$2.82M	Hold	25,000	–	–	﹤0.01%	1990
2014 Q3	$2.68M	Buy	+25,000	New	+$2.69M	﹤0.01%	2008

D.E. Shaw & Co's AMSGP Position: Q4 2016 in Review

D.E. Shaw & Co sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 120,000 shares — an estimated $15.2M sold.

D.E. Shaw & Co first reported a position in AMSGP in Q3 2014 and held it in 9 quarters. The position peaked at $17.4M in Q2 2016. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

D.E. Shaw & Co reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
D.E. Shaw & Co sold 120,000 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $15.2M.
D.E. Shaw & Co first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2014 and held it in 9 quarters.
D.E. Shaw & Co's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $17.4M in Q2 2016.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.